Bobo Donald E Jr sold 23,145 shares of Edwards Lifesciences Corp at $86.42 for −$2.00M on May 27, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CVP,Strategy/Corp Development
CVP,Strategy/Corp Development
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$2,000,193.21Shares × reported price
Shares traded
23,145Common Stock
Price per share
$86.42Reported price. Read footnotes for ranges.
% of reported position traded
19.01%This security and ownership context
Holdings after
98,611Indirect · By Trust
Trade date
May 27, 2026Sell
Filed
May 27, 2026, 7:28 PM ET0-day reporting delay
Accession
0001225208-26-005610Code S · Transaction 91455
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 121,756 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

EW price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
EW · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −3.5%1w ago −4.1%1d ago +1.2%
Returns since7d −0.6%30d +4.9%90d +4.2%180d1y

Footnotes in full

F1: This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.